← Back to Search

PAD Education Video for Peripheral Arterial Disease

N/A
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient undergoing surgery for PAD in Division of Vascular Surgery at Northwestern Memorial Hospital
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to six-month follow-up
Awards & highlights

Study Summary

This trial will test whether an online multimedia patient education video, in addition to the current education regimen, will improve peripheral artery disease (PAD) knowledge, activation, and self-care engagement among patients undergoing surgery for PAD.

Who is the study for?
The STEPUP trial is for patients scheduled for surgery to treat Peripheral Arterial Disease (PAD) at Northwestern Memorial Hospital. It's not open to those who were in the pilot study, have already seen the PAD education video, or can't consent or follow the study rules.Check my eligibility
What is being tested?
This trial tests if adding an online patient education video about PAD to existing educational materials helps improve patients' understanding of their condition and self-care after surgery. Participants are split into two groups: one with standard education and one with additional video content.See study design
What are the potential side effects?
Since this intervention involves an educational video, there aren't any direct medical side effects expected from participating in this clinical trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having surgery for PAD at Northwestern Memorial Hospital.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to six-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to six-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Readiness to change self-care engagement
Secondary outcome measures
Activation level
PAD knowledge and beliefs
Self-efficacy

Trial Design

2Treatment groups
Active Control
Group I: Current education regimenActive Control1 Intervention
Participants will be given a PAD pamphlet and ad hoc verbal teaching by vascular providers.
Group II: InterventionActive Control1 Intervention
Participants will be given the current education regimen and watch a 20 minute online PAD education video.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
916,831 Total Patients Enrolled
24 Trials studying Peripheral Arterial Disease
4,272 Patients Enrolled for Peripheral Arterial Disease

Media Library

Peripheral Arterial Disease Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05445375 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing call for participants in this trial?

"According to clinicaltrials.gov, this investigation is currently in the recruitment phase after being posted on June 7th 2022 and updated most recently on September 28th of that same year."

Answered by AI

How many participants are being accepted into the clinical trial at this point?

"Affirmative. According to information on clinicaltrials.gov, this research effort is still calling for volunteers and has been since it was first posted on June 7th 2022. The trial requires 150 participants from one single medical centre and its details have most recently been updated on September 28th 2022."

Answered by AI
~54 spots leftby Jun 2025